The real-world effectiveness and safety of vedolizumab for moderate-severe Crohn's disease: Results from the US VICTORY consortium

Parambir S. Dulai, Siddharth Singh, Xiaoqian Jiang, Farhad Peerani, Neeraj Narula, Khadija Chaudrey, Diana Whitehead, David Hudesman, Dana Lukin, Arun Swaminath, Eugenia Shmidt, Shuang Wang, Brigid S. Boland, John T. Chang, Sunanda Kane, Corey A. Siegel, Edward V. Loftus, William J. Sandborn, Bruce E. Sands, Jean Frederic Colombel